# An Observational Study in Patients With Breast Cancer and Bone Metastases Receiving Ibandronate (Bondronat)

> **NCT02553850** · — · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 442 (actual)

## Conditions studied

- Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02553850
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 442 (ACTUAL)
- **Last updated:** 2016-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02553850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02553850, "An Observational Study in Patients With Breast Cancer and Bone Metastases Receiving Ibandronate (Bondronat)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02553850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*